Skip to content

 

IDBS
Research and Development Software and Solutions
IDBS
  • Solutions
    • BioPharma Research & Discovery
    • BioPharma Development
    • Biopharma Manufacturing
    • Industrials
    • Energy
    • Agriculture
    • Food and Beverage
    • Consumer Goods
  • Products
    • E-WorkBook | Research & Discovery
    • Polar | Biopharma Development
    • Polar BioAnalysis
    • Polar BioProcess
    • Polar HTPD
    • Polar Insight
    • Skyland PIMS
    • ActivityBase
  • Customers
    • Meet Our Customers
    • Customer Success Stories
  • IDBS ecosystem
    • Meet Our Partners
  • Resources
    • Knowledge Center
    • Training & Education
    • Glossary
  • About
    • History
    • Management Team
    • Certifications
    • Careers
    • Part of Danaher
    • Coordinated Vulnerability Disclosure
  • News
    • Events & Webinars
    • Blog
    • Press Releases

 

Contact UsDemo Request
  • Solutions
    • BioPharma Research & Discovery
    • BioPharma Development
    • Biopharma Manufacturing
    • Industrials
    • Energy
    • Agriculture
    • Food and Beverage
    • Consumer Goods
  • Products
    • E-WorkBook | Research & Discovery
    • Polar | Biopharma Development
    • Polar BioAnalysis
    • Polar BioProcess
    • Polar HTPD
    • Polar Insight
    • Skyland PIMS
    • ActivityBase
  • Customers
    • Meet Our Customers
    • Customer Success Stories
  • IDBS ecosystem
    • Meet Our Partners
  • Resources
    • Knowledge Center
    • Training & Education
    • Glossary
  • About
    • History
    • Management Team
    • Certifications
    • Careers
    • Part of Danaher
    • Coordinated Vulnerability Disclosure
  • News
    • Events & Webinars
    • Blog
    • Press Releases
You are here:
  1. Home
  2. 2013
  3. June
  4. 04
Home News Archives for 4th June 2013 | 00:00
UTM: noutm

R&D: Are true drug breakthroughs a thing of the past?

In the newsBy LKapitany4th June 2013 | 00:00

Fierce Biotech June 2013 One of the most intense discussions at ASCO over the past few days has zeroed in on the FDA’s new “breakthrough” drug status. The agency is offering developers essentially an open door at the FDA to…

Terms of Use | Privacy Policy | Terms and Conditions | Do Not Sell or Share My Data | Cookie Settings
Danaher Life Sciences

Go to Top
Search

More results...

Generic filters
Exact matches only
Webinar: Creation of a real-time process data framework with an external manufacturer Register now!
Webinar: Creation of a real-time process data framework with an external manufacturer Register now!